ABBV-221

• Target :

  Microtubule Associated|||Others|||Antibody-Drug Conjugates (ADCs)

• Related Pathways :

  Antibody-drug Conjugate/ADC Related|||Cytoskeletal Signaling|||Others

• Bioactivity :

  ABBV-221 is an intravenously administered drug that modulates the activity of epidermal growth factor receptor (EGFR) and has potential antitumor activity.

• Smiles :

  NA

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C

• CAS Number :

  2085839-29-6